pharma · Type 2 Diabetes Mellitus (T2DM)
Gan & Lee
Gan & Lee Pharmaceuticals.
Gan & Lee is a pharma organization headquartered in CN. Primary therapeutic focus areas include Type 2 Diabetes Mellitus (T2DM). NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to th
CN HQ
1998 Founded
494 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Founded
- 1998
- Employees
- 494
- Programs
- 1
- Drugs
- 1
- Patents
- 0
GZR102
Phase 2 · small molecule · Type 2 Diabetes Mellitus (T2DM)
GZR102 for Type 2 Diabetes Mellitus (T2DM) is a Phase 2 program (small_molecule) at Gan & Lee Pharmaceuticals. with 1 ClinicalTrials.gov record(s).
Internal code GZR102-T2D-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Gan & Lee Pharmaceuticals.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Type 2 Diabetes Mellitus (T2DM)
- Status
- active
- Trials
- 1